AGN-INM176
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGN-INM176, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA [Phase 1, Phase 2]